Aníbal Ferreira

Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial

Hiddo J.L. Heerspink, Hans‐Henrik Parving, Dennis L. Andress et al. · The Lancet · 2019 · 589 citations · Full text

Urology, Renal Disease, Renal Events +7

A multicenter study on the effects of lanthanum carbonate (Fosrenol™) and calcium carbonate on renal bone disease in dialysis patients

Patrick C. D’Haese, Goce Spasovski, A. Sikole et al. · Kidney International · 2003 · 327 citations

Hemodialysis, Urology, Renal Function +10

Diagnostic Accuracy of Bone Turnover Markers and Bone Histology in Patients With CKD Treated by Dialysis

Stuart M. Sprague, Ezequiel Bellorín-Font, Vanda Jorgetti et al. · American Journal of Kidney Diseases · 2015 · 291 citations · Full text

End-stage Renal Disease, Bone Turnover Markers, Hemodialysis +12

Plasma total versus bone alkaline phosphatase as markers of bone turnover in hemodialysis patients.

Pablo Ureña, M Hrubý, Aníbal Ferreira et al. · Journal of the American Society of Nephrology · 1996 · 256 citations · Full text

Dialysis Therapy, Hemodialysis Patients, Plasma Bap +17

Cholecalciferol Supplementation in Hemodialysis Patients

Patrícia Matias, Cristina Jorge, Ana Carina Ferreira et al. · Clinical Journal of the American Society of Nephrology · 2010 · 222 citations · Full text